Roger Royse is a startup lawyer in Silicon Valley and a pancreatic cancer patient. Roger was diagnosed with stage 2B pancreatic adenocarcinoma in July 2022 after taking a multi cancer early detection blood test. After 6 months of chemotherapy and surgery and an experimental cancer vaccine, Roger currently has no evidence of disease. Roger has been active for many years with the Leukemia Lymphoma Society having been its Bay area Man of the Year in 2012. Since his diagnosis, Roger has become the Silicon valley Advocacy Chair for the Pancreatic Cancer Action Network (PanCan) and has joined the board of the Cancer Patient Lab.org, a nonprofit dedicated to evidence based therapies. Roger also hosts www.cancerstartup.com, a platform for cancer therapy technology startups to demo their solutions. Roger has since testified to an FDA Advisory committee on multi cancer early detection and has been featured in many publications including the Wall Street Journal on MCED. Roger believes in the patient being proactive and taking personal responsibility for their health and being very involved in their treatment decisions based on evidence based treatments.